ArticleEuropean journal of nuclear medicine and molecular imaging2016

TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.

Kung-Chu Ho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.